Peter Maccallum Cancer Centre, Australia
Clinical trials sponsored by Peter Maccallum Cancer Centre, Australia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan could sniff out hidden fungal infections Results expected Oct 2026 (estimated)
- Melanoma Treatment's hidden cost: study probes fertility damage Results expected Dec 2026 (estimated)
- New Full-Body PET scanner promises faster scans, less radiation Results expected Dec 2026 (estimated)
- Can a PET-MRI tracer reveal where CAR-T cells go in myeloma? Results expected Jan 2027 (estimated)
-
Can a PET-MRI tracer reveal where CAR-T cells go in myeloma?
Disease control OngoingThis phase 1 trial tests whether a special imaging tracer can track CAR-T cells in people with extramedullary myeloma, a type of myeloma that forms tumors outside the bone marrow. Participants receive cilta-cel, a CAR-T therapy targeting the BCMA protein on myeloma cells, along w…
Phase 1 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New scan may spare men from unnecessary prostate biopsies
Diagnosis OngoingThis study tests whether adding a PSMA PET scan helps doctors better diagnose significant prostate cancer in men whose MRI results are unclear or negative. About 660 men with no prior prostate cancer or biopsy will be randomly assigned to receive either standard care or an additi…
Phase 3 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Scientists map skin Cancer's inner workings to decode immunotherapy response
Knowledge-focused OngoingResearchers are studying cutaneous squamous cell carcinoma, a common type of skin cancer, in patients who receive the immunotherapy drug cemiplimab before surgery. The goal is to build a detailed molecular map of the tumor and its surroundings using single-cell sequencing and gen…
Phase 2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
New registry to track PSMA therapy in 500 men with advanced prostate cancer
Knowledge-focused OngoingThis observational registry will follow 500 men with metastatic castration-resistant prostate cancer who are receiving PSMA theranostics (177Lu-PSMA) as part of their standard care. Researchers will track how well the treatment lowers PSA levels and monitor any serious side effec…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New Full-Body PET scanner promises faster scans, less radiation
Knowledge-focused OngoingThis study compares a new total body PET scanner (Omni TB) with conventional PET in 25 adult cancer patients. The new scanner can image the whole body at once with higher sensitivity, potentially allowing shorter scan times and lower radiation doses. Researchers will assess wheth…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC